KLK3 and prostate cancer: Prostate cancer cells produce on their surface the serine protease PSA (prostate-specific antigen) that is capable of cleaving the peptide bond between Gln and Leu, thereby producing an active TG analogue that can enter the cancer cell and kill it by triggering apoptosis.